Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 36Leukemia 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Gastrointestinal Stromal Tumors 13Leukemia, Myeloid, Chronic-Phase 12Leukemia, Myeloid 6Brain Neoplasms 6Prostatic Neoplasms 5Philadelphia Chromosome 5Blast Crisis 5Sarcoma 4Recurrence 4Glioblastoma 4Carcinoma, Non-Small-Cell Lung 4Bone Marrow Diseases 4Ovarian Neoplasms 3Melanoma 3Lung Neoplasms 3Leukemia, Myeloid, Acute 3Hematologic Diseases 3Bronchiolitis Obliterans Syndrome 3Breast Neoplasms 3Stomach Neoplasms 2Polycythemia Vera 2Neurofibromatoses 2Neoplasms by Histologic Type 2Neoplasms 2Neoplasm Metastasis 2Myeloproliferative Disorders 2Meningioma 2

Interventions

Cyclophosphamide 21fludarabine phosphate 18Whole-Body Irradiation 17Methotrexate 17Tacrolimus 15Peripheral Blood Stem Cell Transplantation 15Mycophenolic Acid 13Dexamethasone 11Vincristine 10Etoposide 10Antilymphocyte Serum 10Calcium Dobesilate 9Busulfan 9Rituximab 8Doxorubicin 8merphos 7Filgrastim 7Cytarabine 7Sirolimus 6Prednisone 6Melphalan 6Granulocyte Colony-Stimulating Factor 6Cyclosporine 6pegaspargase 5dexamethasone acetate 5dexamethasone 21-phosphate 5prednylidene 4deltacortene 4auricularum 4Radiotherapy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Imatinib Mesylate × Clear all
NCT01005914 2023-01-06

Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

OHSU Knight Cancer Institute

Phase 2 Terminated
11 enrolled 6 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡